LAC is mine to add to the above mentioned by CR (and holding a few of them). The LAC thread has all the info and it was my one-bagger for 2003 (see the thread). So why will it double again?
The last results and acompanying statement were the most bullish yet from a cautious chairman. The final paragraph outlook outlined where this should be going this year:
"The second half has started encouragingly. The recent grant of our Ecomectin registrations in Europe and the approaching possibility of Aivlosin registrations enable me to look forward with renewed optimism and confidence that our growth rate will accelerate and we will continue to deliver value to our shareholders".
Forecasts for 15p or so should be taken with a pinch of salt. This could be looking at 30p min EPS for 2005 so the forward PE is about 12. This will then be my one bagger for 2005 as well as I can see 100p+ EPS further forward.
Looking for a minimum of £7.50 this year now and expecting £25 at some point further on - all things being equal.
Not without risk obviously - delays rather than other obstacles are possible IMO - but this is like buying into a biotech share without the high risks of research and failure that accompany those shares. LAC has long licences for Ecomectin and Aivlosin which are both proven and believed to be "best of type".
